Several RNA expression studies of BM in different tumors have shown that EGFR/ERK expression is elevated in tumors with brain involvement, and in the case of LC, it has even been found that the expression of the proteins of this pathway is higher in metastases compared to primary tumor (19). This evidence concerns the gene EGFR and laryngotracheoesophageal cleft.